LICENCE AGREEMENTLicence Agreement • March 10th, 2021 • Vaccitech LTD • Pharmaceutical preparations • England and Wales
Contract Type FiledMarch 10th, 2021 Company Industry JurisdictionEach of Vaccitech, Oxford and OUI is referred to as a “Party” and together as the “Parties”; save that OUI shall only be a Party to this Agreement for the purposes of clause 3.
LICENCE AGREEMENTLicence Agreement • March 10th, 2021 • Vaccitech LTD • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2021 Company IndustryCERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED.
DATED 2017Agreement • March 10th, 2021 • Vaccitech LTD • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2021 Company Industry
Clinical Development Partnerships Clinical Trial and Option Agreement Vaccitech Oncology Limited and Cancer Research Technology Limited and Cancer Research UKVaccitech LTD • March 10th, 2021 • Pharmaceutical preparations • England and Wales
Company FiledMarch 10th, 2021 Industry JurisdictionCompany VACCITECH ONCOLOGY LIMITED (“VOLT”), a company registered in England and Wales under number 11655405 with registered office at The Schrodinger Building 2nd Floor, Heatley Road, Oxford Science Park, Oxford, Oxfordshire, England, OX4 4GE